Literature DB >> 3148705

Enhanced liposome-mediated antibacterial activity of piperacillin and gentamicin against gram-negative bacilli in vitro.

M C Nacucchio1, M J Gatto Bellora, D O Sordelli, M D'Aquino.   

Abstract

This study showed that encapsulation of piperacillin (PIP) and gentamicin (GE) by liposomes prepared with phosphatidylcholine and cholesterol (1:1) enhanced the antibiotic activity against gram negative bacilli. This was demonstrated by growth inhibition of Escherichia coli and Pseudomonas aeruginosa in the presence of the liposomal preparations containing either PIP or GE at 50 per cent MIC. Mixtures of liposomes containing buffer and either PIP or GE also exhibited an enhanced activity of the drug against the micro-organisms.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3148705     DOI: 10.3109/02652048809036726

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  10 in total

1.  Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa.

Authors:  Clement Mugabe; Majed Halwani; Ali O Azghani; Robert M Lafrenie; Abdelwahab Omri
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 2.  Pharmacology and toxicology of novel drug delivery systems. Regulatory issues.

Authors:  J Weissinger
Journal:  Drug Saf       Date:  1990       Impact factor: 5.606

3.  The influence of Pseudomonas aeruginosa on liposomes.

Authors:  M Antos; E A Trafny; J Grzybowski
Journal:  Folia Microbiol (Praha)       Date:  1996       Impact factor: 2.099

4.  Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation.

Authors:  M S Webb; N L Boman; D J Wiseman; D Saxon; K Sutton; K F Wong; P Logan; M J Hope
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

5.  Effects of free and liposome-encapsulated antibiotics on adherence of Pseudomonas aeruginosa to collagen type I.

Authors:  E A Trafny; M Stepińska; M Antos; J Grzybowski
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

6.  The effect of liposomal cefoperazone against Pseudomonas aeruginosa in a granulocytopenic mouse model of acute lung infection.

Authors:  P H Di Rocco; M C Nacucchio; D O Sordelli; F Mancuso; A M Hooke
Journal:  Infection       Date:  1992 Nov-Dec       Impact factor: 3.553

7.  Intracellular delivery and antibacterial activity of gentamicin encapsulated in pH-sensitive liposomes.

Authors:  P Lutwyche; C Cordeiro; D J Wiseman; M St-Louis; M Uh; M J Hope; M S Webb; B B Finlay
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

8.  Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa.

Authors:  A Omri; C Beaulac; M Bouhajib; S Montplaisir; M Sharkawi; J Lagacé
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

9.  Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound.

Authors:  Feng-Yi Yang; Hsin-Ell Wang; Ren-Shyan Liu; Ming-Che Teng; Jia-Je Li; Maggie Lu; Ming-Cheng Wei; Tai-Tong Wong
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

10.  Behavioral alterations following blood-brain barrier disruption stimulated by focused ultrasound.

Authors:  Feng-Yi Yang; Sheng-Fang Huang; Irene Han-Juo Cheng
Journal:  Oncotarget       Date:  2016-05-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.